Success Metrics

Clinical Success Rate
90.0%

Based on 27 completed trials

Completion Rate
90%(27/30)
Active Trials
16(29%)
Results Posted
56%(15 trials)
Terminated
3(5%)

Phase Distribution

Ph phase_2
1
2%
Ph phase_3
2
4%
Ph early_phase_1
2
4%
Ph not_applicable
35
63%
Ph phase_4
4
7%

Phase Distribution

2

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution44 total trials
Early Phase 1First-in-human
2(4.5%)
Phase 2Efficacy & side effects
1(2.3%)
Phase 3Large-scale testing
2(4.5%)
Phase 4Post-market surveillance
4(9.1%)
N/ANon-phased studies
35(79.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

27 of 33 finished

Non-Completion Rate

18.2%

6 ended early

Currently Active

16

trials recruiting

Total Trials

56

all time

Status Distribution
Active(18)
Completed(27)
Terminated(6)
Other(5)

Detailed Status

Completed27
Recruiting14
unknown5
Withdrawn3
Terminated3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
56
Active
16
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (4.5%)
Phase 21 (2.3%)
Phase 32 (4.5%)
Phase 44 (9.1%)
N/A35 (79.5%)

Trials by Status

enrolling_by_invitation12%
recruiting1425%
unknown59%
completed2748%
active_not_recruiting24%
withdrawn35%
not_yet_recruiting12%
terminated35%

Recent Activity

Clinical Trials (56)

Showing 20 of 56 trialsScroll for more
NCT07221812Not Applicable

Continuous Glucose Monitors (CGMs) and Readmission Rates

Not Yet Recruiting
NCT05337826Not Applicable

The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes

Active Not Recruiting
NCT06501612Not Applicable

Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7

Completed
NCT07448805Not Applicable

Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit

Recruiting
NCT04614168Not Applicable

Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes

Completed
NCT06184373

Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot

Recruiting
NCT06648174Not Applicable

The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus

Recruiting
NCT06858787Not Applicable

Validating CGM for GDM

Recruiting
NCT07065721Not Applicable

Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

Recruiting
NCT05937373Not Applicable

Perioperative Continuous Glucose Monitoring

Terminated
NCT05124405Not Applicable

Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices

Active Not Recruiting
NCT06643611Not Applicable

Addressing Disparities in Diabetes Care

Completed
NCT07184775Not Applicable

CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes

Recruiting
NCT05548205Not Applicable

Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge

Recruiting
NCT05317585Not Applicable

Continuous Glucose Monitor Use in Pregnancy

Recruiting
NCT07174245

Pregnancy and Postpartum CGM in GDM

Recruiting
NCT04219085Not Applicable

CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes

Completed
NCT05944718Not Applicable

Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in South Africa

Completed
NCT06517576Not Applicable

Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes

Enrolling By Invitation
NCT06436326Not Applicable

The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes

Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
56